Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07694518

Role of Endoscopic Third Ventriculostomy Imanagement of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome

Endoscopic third ventriculostomy in cases of hydrocephalus provide less invasive and safe technique than ventriculoperitoneal Shunt also decrease complications of ventriculoperitoneal Shunt

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Age range

6 month–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Endoscopic third ventriculostomy (ETV) is a minimally invasive neurosurgical procedure used to treat obstructive hydrocephalus in children. By creating an opening in the floor of the third ventricle, the surgeon establishes a new pathway for cerebrospinal fluid (CSF) to bypass the blockage and drain naturally, potentially eliminating the need for a traditional brain shunt.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cases hydrocephalus diagnosed by CT or MRI.in pediatric age group up to 18 years
  • Both sex (males and females) will be included.

Exclusion criteria

  • cases with hydrocephalus associated with csf infection or hemorrhage
  • Previously operated VP shunt or ETV .
  • Mult cystic hydrocephalus

Treatment and study plan

Fenestration of the floor of the third ventricle

Procedure

Endoscopic third ventriculostomy of the third ventricle of the brain

Endoscopic third ventriculostomy of the brain third ventricle

Procedure

Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

Endoscopic third ventriculostomy

Procedure

Surgeons insert a rigid endoscope through a small burr hole in the skull into the ventricular system. They use a catheter or laser to puncture a tiny, precise opening in the floor of the third ventricle

Primary outcomes

  1. Changes in manifestation according to ETVSS endoscopic third ventriculostomy success score with assement of level of consciousness degree of papiledema and severity of headache

    Time frame: 6 month

    ETVSS ETV success score is predictive tool used to estimate ETV success based on factors like age etiology previous shunt other pathologies The score is expressed as a number from 0 to 90 with assement of level of consciousness degree of papiledema and severity of headache Score 70 indicate an estimated 70 % chance of success

Study contacts

Contact information is provided by the study sponsor or research team.

Ahmed Esmael Marzouk, Resident

CONTACT

[email protected]

201156294688 ext. 201004213207

Sponsors and collaborators

Lead sponsor

Sohag University

Other

Registry information

Official study title

Role of Endoscopic Third Ventriculostomy in Management of Hydrocephalus in Pediatric Age Group; Clinical and Surgical Outcome

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Jul 10, 2026
Registry last updated
Jul 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.